Credit Suisse Ag Immunovant, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Immunovant, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 68,119 shares of IMVT stock, worth $1.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

68,119

Previous 56,056 21.52%

Holding current value

$1.87 Million

Previous $2.36 Million 6.82%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$30.27 - $43.79 $365,147 - $528,238	12,063 Added 21.52%	68,119 $2.2 Million
Q4 2023 Feb 08, 2024	BUY	$31.31 - $44.19 $751 - $1,060	24 Added 0.04%	56,056 $2.36 Million
Q3 2023 Nov 13, 2023	SELL	$18.55 - $39.96 $121,725 - $262,217	-6,562 Reduced 10.48%	56,032 $2.15 Million
Q2 2023 Aug 11, 2023	BUY	$14.2 - $23.75 $173,126 - $289,560	12,192 Added 24.19%	62,594 $1.19 Million
Q1 2023 May 10, 2023	BUY	$15.27 - $19.72 $22,767 - $29,402	1,491 Added 3.05%	50,402 $781,000

Q4 2022 Feb 13, 2023	BUY	$6.59 - $17.75 $56,884 - $153,218	8,632 Added 21.43%	48,911 $868,000
Q3 2022 Nov 10, 2022	BUY	$3.93 - $6.37 $12,835 - $20,804	3,266 Added 8.82%	40,279 $225,000
Q2 2022 Aug 12, 2022	BUY	$3.38 - $5.65 $7,233 - $12,091	2,140 Added 6.14%	37,013 $145,000
Q1 2022 May 16, 2022	BUY	$5.06 - $8.77 $57,749 - $100,092	11,413 Added 48.65%	34,873 $192,000
Q4 2021 Feb 14, 2022	BUY	$7.33 - $9.32 $14,806 - $18,826	2,020 Added 9.42%	23,460 $200,000
Q3 2021 Nov 12, 2021	SELL	$7.01 - $11.37 $330,444 - $535,970	-47,139 Reduced 68.74%	21,440 $186,000
Q2 2021 Aug 16, 2021	BUY	$9.4 - $16.85 $190,509 - $341,498	20,267 Added 41.95%	68,579 $724,000
Q1 2021 May 14, 2021	SELL	$13.08 - $49.6 $226,179 - $857,683	-17,292 Reduced 26.36%	48,312 $775,000
Q4 2020 Feb 12, 2021	BUY	$36.36 - $52.71 $964,194 - $1.4 Million	26,518 Added 67.85%	65,604 $3.03 Million
Q3 2020 Nov 13, 2020	BUY	$22.61 - $38.9 $581,257 - $1 Million	25,708 Added 192.17%	39,086 $1.38 Million
Q2 2020 Aug 12, 2020	BUY	$13.87 - $28.44 $185,552 - $380,470	13,378 New	13,378 $325,000

Others Institutions Holding IMVT

# of Institutions

238

Shares Held

62.9M

Call Options Held

1.46M

Put Options Held

546K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account